+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID05021198

Study of Cerebral Venous Thrombosis in Norway Examining Diagnosis, Treatment, and Long-Term Outcomes from 2014 to 2023

Led by University Hospital, Akershus · Updated on 2025-02-05

600

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying cerebral venous thrombosis CVT in a large Norwegian population of over 3 million people to better understand its causes, diagnosis, treatment, and long-term outcomes. The study combines data from multiple health registries, clinical databases, and newly collected clinical information to explore the diseases epidemiology and prognosis from 2014 to 2023. The study includes a retrospective review of hospital records from 13 hospitals covering all health regions in Norway, identifying patients diagnosed with CVT during this period. These data are linked with national registries to describe risk factors, clinical and radiological presentation, treatments, and short-term outcomes. Additionally, the study follows patients up to five years after CVT diagnosis to assess mortality, healthcare use, medication patterns, work status, and other long-term results. Participants diagnosed with CVT from 2019 to 2023 will also be invited for prospective follow-up, including interviews and questionnaires to evaluate quality of life, psychological health, vocational outcomes, and disease-related disability. The primary outcome measures include mortality rates at multiple time points, and secondary outcomes cover healthcare utilization, medication use, re-admissions, new diagnoses, and symptoms such as headache, seizures, and sleep problems over a five-year period.

CONDITIONS

Brief Title

The Norwegian Cerebral Venous Thrombosis Study

Research Team

E

Espen Saxhaug Kristoffersen, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here